Quick Dispatch:
Your iih glp 1 Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your iih glp 1 Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study ships.
Need Help?
Questions about iih glp 1 Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for iih glp 1 Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study in your area.
Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals
23.62
GLP-1 Receptor Agonists Significantly Improve Effects of Idiopathic Intracranial Hypertension
22.77
GLP-1 medications and pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih
22.87
A retrospective cohort study assessed outcomes among patients with idiopathic intracranial hypertension who received glucagon-like peptide-1 receptor agonists
28.63
Metabolic pathogenesis and treatment in IIH. IIH is most prevalent in
29.52
Recurrent Idiopathic Intracranial Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema
20.54
Management of IIH. The treatment of IIH focuses on vision preservation
21.25
